SK Biopharmaceuticals Co Ltd
KRX:326030

Watchlist Manager
SK Biopharmaceuticals Co Ltd Logo
SK Biopharmaceuticals Co Ltd
KRX:326030
Watchlist
Price: 104 000 KRW -0.1% Market Closed
Market Cap: 8.1T KRW
Have any thoughts about
SK Biopharmaceuticals Co Ltd?
Write Note

Operating Margin
SK Biopharmaceuticals Co Ltd

8.7%
Current
-18%
Average
6.9%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
8.7%
=
Operating Profit
40.4B
/
Revenue
465.1B

Operating Margin Across Competitors

Country KR
Market Cap 8.1T KRW
Operating Margin
9%
Country JP
Market Cap 776 550.9T JPY
Operating Margin
-83%
Country US
Market Cap 756.5B USD
Operating Margin
35%
Country UK
Market Cap 440.4B GBP
Operating Margin
3%
Country DK
Market Cap 3.3T DKK
Operating Margin
44%
Country US
Market Cap 364.1B USD
Operating Margin
28%
Country US
Market Cap 248.4B USD
Operating Margin
34%
Country CH
Market Cap 208.5B CHF
Operating Margin
32%
Country CH
Market Cap 181.2B CHF
Operating Margin
29%
Country UK
Market Cap 159.6B GBP
Operating Margin
21%
Country IE
Market Cap 146B USD
Operating Margin
11%

Profitability Report

View the profitability report to see the full profitability analysis for SK Biopharmaceuticals Co Ltd.

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
8.7%
=
Operating Profit
40.4B
/
Revenue
465.1B
What is the Operating Margin of SK Biopharmaceuticals Co Ltd?

Based on SK Biopharmaceuticals Co Ltd's most recent financial statements, the company has Operating Margin of 8.7%.